A.forall Launches Generic Tromethamine With 180-Day US Exclusivity

Launch Marks The Second A.forall Product With The Coveted CGT Designation

 
• By Adam Zamecnik

The commercialization of the generic version of Hospira’s THAM solution will be carried out by A.forall’s US subsidiary Milla Pharmaceuticals.

Map of US showing individual states
Teva has settled with “all 50 states and 99% of litigating subdivisions” • Source: Shutterstock

More from Business

More from Generics Bulletin